医学临床研究
醫學臨床研究
의학림상연구
JOURNAL OF CLINICAL RESEARCH
2014年
10期
1980-1982,1985
,共4页
沙立度胺/治疗应用%胃肠出血/药物疗法%消化系统/血液供给%血管/畸形
沙立度胺/治療應用%胃腸齣血/藥物療法%消化繫統/血液供給%血管/畸形
사립도알/치료응용%위장출혈/약물요법%소화계통/혈액공급%혈관/기형
Thalidomide/TU%Gastrointestinal Hemorrhage/DT%Digestive System/BS%Blood Ves-sels/AB
【目的】探讨沙利度胺治疗胃肠道血管畸形所致消化道出血的作用机制。【方法】采用免疫组化法检测90例GIVM 所致消化道出血患者,及30例健康人肠黏膜中促血管生成素‐2(Ang‐2)、Notch‐1、DLL4的表达;采用RT‐PCR及Western blot检测50 mg/L、100 mg/L、200 mg/L沙利度胺对HUVEC细胞Ang‐2、Notch‐1、DLL4基因mRNA及蛋白表达的影响。【结果】与溶剂对照组比较,50 mg/L沙利度胺组中Notch‐1的mRNA表达量减少,100 mg/L沙利度胺组中Ang‐2,Notch‐1的mRNA表达量减少,差异具有统计学意义( P <0.05),200 mg/L沙利度胺组中Ang‐2,Notch‐1,DII4的mRNA表达量减少,差异均有统计学意义( P <0.05)。与溶剂对照组比较,50 mg/L沙利度胺组中 Ang‐2、Notch‐1的蛋白表达量下降,100 mg/L ,200 mg/L沙利度胺组中的 Ang‐2, Notch‐1,DLL4的蛋白表达量均下降,差异都具有统计学意义( P <0.05)。GIVM组织中血管扩张扭曲。Ang‐2的表达明显增高。DLL4和Notch‐1的表达在病变组织中亦明显增高。而胃肠道血管畸形(GIVM )患者非病变组织及健康体检者正常肠黏膜组织中Ang‐2、Notch‐1、DLL4均呈弱阳性(+)或阴性表达。【结果】GIVM 与Ang‐2、DLL4和Notch‐1的表达密切相关,且沙利度胺可抑制Ang‐2、DLL4和Notch‐1的mRNA及蛋白的表达。
【目的】探討沙利度胺治療胃腸道血管畸形所緻消化道齣血的作用機製。【方法】採用免疫組化法檢測90例GIVM 所緻消化道齣血患者,及30例健康人腸黏膜中促血管生成素‐2(Ang‐2)、Notch‐1、DLL4的錶達;採用RT‐PCR及Western blot檢測50 mg/L、100 mg/L、200 mg/L沙利度胺對HUVEC細胞Ang‐2、Notch‐1、DLL4基因mRNA及蛋白錶達的影響。【結果】與溶劑對照組比較,50 mg/L沙利度胺組中Notch‐1的mRNA錶達量減少,100 mg/L沙利度胺組中Ang‐2,Notch‐1的mRNA錶達量減少,差異具有統計學意義( P <0.05),200 mg/L沙利度胺組中Ang‐2,Notch‐1,DII4的mRNA錶達量減少,差異均有統計學意義( P <0.05)。與溶劑對照組比較,50 mg/L沙利度胺組中 Ang‐2、Notch‐1的蛋白錶達量下降,100 mg/L ,200 mg/L沙利度胺組中的 Ang‐2, Notch‐1,DLL4的蛋白錶達量均下降,差異都具有統計學意義( P <0.05)。GIVM組織中血管擴張扭麯。Ang‐2的錶達明顯增高。DLL4和Notch‐1的錶達在病變組織中亦明顯增高。而胃腸道血管畸形(GIVM )患者非病變組織及健康體檢者正常腸黏膜組織中Ang‐2、Notch‐1、DLL4均呈弱暘性(+)或陰性錶達。【結果】GIVM 與Ang‐2、DLL4和Notch‐1的錶達密切相關,且沙利度胺可抑製Ang‐2、DLL4和Notch‐1的mRNA及蛋白的錶達。
【목적】탐토사리도알치료위장도혈관기형소치소화도출혈적작용궤제。【방법】채용면역조화법검측90례GIVM 소치소화도출혈환자,급30례건강인장점막중촉혈관생성소‐2(Ang‐2)、Notch‐1、DLL4적표체;채용RT‐PCR급Western blot검측50 mg/L、100 mg/L、200 mg/L사리도알대HUVEC세포Ang‐2、Notch‐1、DLL4기인mRNA급단백표체적영향。【결과】여용제대조조비교,50 mg/L사리도알조중Notch‐1적mRNA표체량감소,100 mg/L사리도알조중Ang‐2,Notch‐1적mRNA표체량감소,차이구유통계학의의( P <0.05),200 mg/L사리도알조중Ang‐2,Notch‐1,DII4적mRNA표체량감소,차이균유통계학의의( P <0.05)。여용제대조조비교,50 mg/L사리도알조중 Ang‐2、Notch‐1적단백표체량하강,100 mg/L ,200 mg/L사리도알조중적 Ang‐2, Notch‐1,DLL4적단백표체량균하강,차이도구유통계학의의( P <0.05)。GIVM조직중혈관확장뉴곡。Ang‐2적표체명현증고。DLL4화Notch‐1적표체재병변조직중역명현증고。이위장도혈관기형(GIVM )환자비병변조직급건강체검자정상장점막조직중Ang‐2、Notch‐1、DLL4균정약양성(+)혹음성표체。【결과】GIVM 여Ang‐2、DLL4화Notch‐1적표체밀절상관,차사리도알가억제Ang‐2、DLL4화Notch‐1적mRNA급단백적표체。
[Objective]To explore the action mechanism of thalidomide for the treatment of gastrointestinal bleeding caused by gastrointestinal vascular malformation (GIVM ) .[Methods]The expression of Ang‐2 ,Notchl and DLL4 in intestinal mucosa of 90 patients with gastrointestinal bleeding caused by GIVM and 30 healthy per‐sons were detected by using immunohistochemical method .RT‐PCR and Western blot were used to detect the im‐pact of 50mg/L ,100mg/L and 200mg/L thalidomide on the mRNA and protein expression of Ang‐2 ,Notchl and DLL4 gene in HUVEC cells .[Results]Compared with solvent control group ,the mRNA expression of Notch1 in 50mg/L thalidomide group was reduced ,and the mRNA expression of Ang‐2 and Notch1 in 100mg/L thalidomide group were reduced ,and there was significant difference( P <0 .05) .The mRNA expression of Ang‐2 ,Notch1 and DLL4 in 200mg/L thalidomide group were reduced ,and there was significant difference( P <0 .05) .Com‐pared with solvent control group ,the protein expression of Ang‐2 and Notch1 in 50mg/L thalidomide group were reduced ,and the protein expression of Ang‐2 ,Notch1 and DLL4 in 100mg/L and 200mg/L thalidomide group were reduced ,and there was significant difference( P <0 .05) .The expression of Ang‐2 in vasodilation distortion tissues of GIVM was increased obviously ,and the expression of DLL4 and Notchl in the diseased tissues was also increased obviously .The expression of Ang‐2 ,Notchl and DLL4 in non‐diseased tissues of GIVM patients and normal intestinal mucosa tissues of healthy persons were weakly positive (+ ) or negative .[Conclusion]GIVM is closely associated with the expression of Ang‐2 ,DLL4 and Notchl .Thalidomide can inhibit the mRNA and protein expression of Ang‐2 ,DLL4 and Notchl .